Onset of Huntington's disease: can it be purely cognitive?
Identifieur interne : 000497 ( PubMed/Checkpoint ); précédent : 000496; suivant : 000498Onset of Huntington's disease: can it be purely cognitive?
Auteurs : Jane S. Paulsen [États-Unis] ; Jeffrey D. LongSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.
English descriptors
- KwdEn :
- Adult, Cognition Disorders (diagnosis), Cognition Disorders (etiology), Female, Humans, Huntington Disease (complications), Huntington Disease (genetics), Longitudinal Studies, Male, Middle Aged, Nerve Tissue Proteins (genetics), Neuropsychological Tests, Severity of Illness Index, Trinucleotide Repeat Expansion (genetics).
- MESH :
- chemical , genetics : Nerve Tissue Proteins.
- complications : Huntington Disease.
- diagnosis : Cognition Disorders.
- etiology : Cognition Disorders.
- genetics : Huntington Disease, Trinucleotide Repeat Expansion.
- Adult, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Severity of Illness Index.
Abstract
Knowledge of the cognitive manifestation of Huntington's disease has burgeoned over the past two decades. Many studies from independent datasets have shown that cognitive impairment is evident before motor diagnosis, and annual cognitive decline is a robust marker of disease progression. Additionally, cognition is a critical concern to patients and families and is associated with meaningful outcomes, including functional capacity, driving, loss of accustomed work, and quality of life. In the past few years, Huntington's disease animal models of cognition have increased, preparing for preclinical experimental therapeutics with cognitive endpoints. A longitudinal analysis of cognitive variables was conducted with 559 gene-positive cases and 233 controls showing no signs of motor abnormalities over approximately a 3-year period. Results show statistically significant differences in rate of annual change for some cognitive variables, such that the cases group had worsening performance over time. These findings show that cognitive deterioration can be seen in persons with the Huntington's disease gene expansion with no overt motor signs or symptoms, suggesting that cognitive onset of Huntington's disease may precede motor.
DOI: 10.1002/mds.25997
PubMed: 25142616
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25142616Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Onset of Huntington's disease: can it be purely cognitive?</title>
<author><name sortKey="Paulsen, Jane S" sort="Paulsen, Jane S" uniqKey="Paulsen J" first="Jane S" last="Paulsen">Jane S. Paulsen</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Neurology, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Psychology, The University of Iowa, Iowa City, IA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Neurology, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Psychology, The University of Iowa, Iowa City, IA</wicri:regionArea>
<placeName><region type="state">Iowa</region>
<settlement type="city">Iowa City</settlement>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
<author><name sortKey="Long, Jeffrey D" sort="Long, Jeffrey D" uniqKey="Long J" first="Jeffrey D" last="Long">Jeffrey D. Long</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25142616</idno>
<idno type="pmid">25142616</idno>
<idno type="doi">10.1002/mds.25997</idno>
<idno type="wicri:Area/PubMed/Corpus">000418</idno>
<idno type="wicri:Area/PubMed/Curation">000418</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000497</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Onset of Huntington's disease: can it be purely cognitive?</title>
<author><name sortKey="Paulsen, Jane S" sort="Paulsen, Jane S" uniqKey="Paulsen J" first="Jane S" last="Paulsen">Jane S. Paulsen</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Neurology, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Psychology, The University of Iowa, Iowa City, IA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Neurology, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Psychology, The University of Iowa, Iowa City, IA</wicri:regionArea>
<placeName><region type="state">Iowa</region>
<settlement type="city">Iowa City</settlement>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
<author><name sortKey="Long, Jeffrey D" sort="Long, Jeffrey D" uniqKey="Long J" first="Jeffrey D" last="Long">Jeffrey D. Long</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Cognition Disorders (diagnosis)</term>
<term>Cognition Disorders (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Huntington Disease (complications)</term>
<term>Huntington Disease (genetics)</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nerve Tissue Proteins (genetics)</term>
<term>Neuropsychological Tests</term>
<term>Severity of Illness Index</term>
<term>Trinucleotide Repeat Expansion (genetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Huntington Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Huntington Disease</term>
<term>Trinucleotide Repeat Expansion</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neuropsychological Tests</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Knowledge of the cognitive manifestation of Huntington's disease has burgeoned over the past two decades. Many studies from independent datasets have shown that cognitive impairment is evident before motor diagnosis, and annual cognitive decline is a robust marker of disease progression. Additionally, cognition is a critical concern to patients and families and is associated with meaningful outcomes, including functional capacity, driving, loss of accustomed work, and quality of life. In the past few years, Huntington's disease animal models of cognition have increased, preparing for preclinical experimental therapeutics with cognitive endpoints. A longitudinal analysis of cognitive variables was conducted with 559 gene-positive cases and 233 controls showing no signs of motor abnormalities over approximately a 3-year period. Results show statistically significant differences in rate of annual change for some cognitive variables, such that the cases group had worsening performance over time. These findings show that cognitive deterioration can be seen in persons with the Huntington's disease gene expansion with no overt motor signs or symptoms, suggesting that cognitive onset of Huntington's disease may precede motor.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">25142616</PMID>
<DateCreated><Year>2014</Year>
<Month>09</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>05</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>09</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>29</Volume>
<Issue>11</Issue>
<PubDate><Year>2014</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Onset of Huntington's disease: can it be purely cognitive?</ArticleTitle>
<Pagination><MedlinePgn>1342-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25997</ELocationID>
<Abstract><AbstractText>Knowledge of the cognitive manifestation of Huntington's disease has burgeoned over the past two decades. Many studies from independent datasets have shown that cognitive impairment is evident before motor diagnosis, and annual cognitive decline is a robust marker of disease progression. Additionally, cognition is a critical concern to patients and families and is associated with meaningful outcomes, including functional capacity, driving, loss of accustomed work, and quality of life. In the past few years, Huntington's disease animal models of cognition have increased, preparing for preclinical experimental therapeutics with cognitive endpoints. A longitudinal analysis of cognitive variables was conducted with 559 gene-positive cases and 233 controls showing no signs of motor abnormalities over approximately a 3-year period. Results show statistically significant differences in rate of annual change for some cognitive variables, such that the cases group had worsening performance over time. These findings show that cognitive deterioration can be seen in persons with the Huntington's disease gene expansion with no overt motor signs or symptoms, suggesting that cognitive onset of Huntington's disease may precede motor.</AbstractText>
<CopyrightInformation>© 2014 International Parkinson and Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paulsen</LastName>
<ForeName>Jane S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo><Affiliation>Department of Psychiatry, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Neurology, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA; Department of Psychology, The University of Iowa, Iowa City, IA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Long</LastName>
<ForeName>Jeffrey D</ForeName>
<Initials>JD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>5R01NS040068</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>5R01NS054893</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>M01 RR000059</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 NS040068</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 NS054893</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 NS082089</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>08</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Nurs Meas. 2010;18(2):83-99</RefSource>
<PMID Version="1">20806651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 Nov 15;25(15):2595-603</RefSource>
<PMID Version="1">20623772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychology. 2011 Jan;25(1):1-14</RefSource>
<PMID Version="1">20919768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Exp Neuropsychol. 2011 Jun;33(5):567-79</RefSource>
<PMID Version="1">21302170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Neurol Neurosci Rep. 2011 Oct;11(5):474-83</RefSource>
<PMID Version="1">21861097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):751-63</RefSource>
<PMID Version="1">21858921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2012 Mar 15;21(6):1203-16</RefSource>
<PMID Version="1">22116937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Front Biosci (Schol Ed). 2013;5:1-18</RefSource>
<PMID Version="1">23277034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain Res Bull. 2013 Mar;92:29-40</RefSource>
<PMID Version="1">22588013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 2013 Oct;248:457-69</RefSource>
<PMID Version="1">23911978</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1233-9</RefSource>
<PMID Version="1">23911948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prog Neurobiol. 2013 Nov;110:2-28</RefSource>
<PMID Version="1">24036231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2014 Mar;29(3):311-9</RefSource>
<PMID Version="1">24150908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2000 Jan 25;54(2):452-8</RefSource>
<PMID Version="1">10668713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2001 Mar;16(2):325-30</RefSource>
<PMID Version="1">11295789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):120-2</RefSource>
<PMID Version="1">12486282</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Nerv Ment Dis. 2004 Jan;192(1):72-4</RefSource>
<PMID Version="1">14718780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2004 Apr;65(4):267-77</RefSource>
<PMID Version="1">15025718</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Neuropsychol. 1984 Nov;6(4):401-12</RefSource>
<PMID Version="1">6238979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Annu Rev Neurosci. 1986;9:357-81</RefSource>
<PMID Version="1">3085570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):172-7</RefSource>
<PMID Version="1">9489526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neuropathol Exp Neurol. 1998 May;57(5):369-84</RefSource>
<PMID Version="1">9596408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Schizophr Bull. 2005 Jan;31(1):5-19</RefSource>
<PMID Version="1">15888422</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37</RefSource>
<PMID Version="1">17995471</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Neurol. 2007 Dec;14(12):1344-50</RefSource>
<PMID Version="1">17941857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):320-5</RefSource>
<PMID Version="1">17948904</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Apr 15;23(5):721-6</RefSource>
<PMID Version="1">18175350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80</RefSource>
<PMID Version="1">18096682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2010 Jun;16(5):345-50</RefSource>
<PMID Version="1">20236854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2010 Jul 30;178(2):414-8</RefSource>
<PMID Version="1">20471695</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Genet Couns. 2010 Aug;19(4):343-52</RefSource>
<PMID Version="1">20309619</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2010 Sep;153B(6):1150-9</RefSource>
<PMID Version="1">20468062</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2010 Aug 10;75(6):500-7</RefSource>
<PMID Version="1">20610833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):612-9</RefSource>
<PMID Version="1">22451099</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Behav Neurosci. 2012 Jun;126(3):479-87</RefSource>
<PMID Version="1">22642889</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Genet Couns. 2012 Oct;21(5):662-70</RefSource>
<PMID Version="1">22278219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neural Transm. 2012 Nov;119(11):1361-5</RefSource>
<PMID Version="1">22398875</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006816">Huntington Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009419">Nerve Tissue Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019680">Trinucleotide Repeat Expansion</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS619704</OtherID>
<OtherID Source="NLM">PMC4193504</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Huntington's disease</Keyword>
<Keyword MajorTopicYN="N">cognition</Keyword>
<Keyword MajorTopicYN="N">diagnosis</Keyword>
<Keyword MajorTopicYN="N">nonmotor</Keyword>
<Keyword MajorTopicYN="N">onset</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>6</Month>
<Day>6</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>7</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>7</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2014</Year>
<Month>8</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>8</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>8</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>5</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25142616</ArticleId>
<ArticleId IdType="doi">10.1002/mds.25997</ArticleId>
<ArticleId IdType="pmc">PMC4193504</ArticleId>
<ArticleId IdType="mid">NIHMS619704</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Iowa</li>
</region>
<settlement><li>Iowa City</li>
</settlement>
<orgName><li>Université de l'Iowa</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Long, Jeffrey D" sort="Long, Jeffrey D" uniqKey="Long J" first="Jeffrey D" last="Long">Jeffrey D. Long</name>
</noCountry>
<country name="États-Unis"><region name="Iowa"><name sortKey="Paulsen, Jane S" sort="Paulsen, Jane S" uniqKey="Paulsen J" first="Jane S" last="Paulsen">Jane S. Paulsen</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000497 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000497 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:25142616 |texte= Onset of Huntington's disease: can it be purely cognitive? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25142616" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |